Sunday, February 21, 2010


The senate has released a report accusing pharmaceutical manufacturer GlaxoSmithKline of hiding the increased risk of heart attacks for users of their diabetes medicine, Avandia. How much of a risk exactly?
• "FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came to market."

Just to put that number in perspective, 83,000 is exactly 83,000 more heart attacks than should be caused by something the FDA considers a medicine.

Good job once again, U S Food and Drug Administration.

No comments: